Decision Diagnostics Corp (DECN)

[pro-trader]

What happened to this firm?
So far on track and this year projection is about 70 million in revenues


6250
$65 million - $75 million in 2011.
that the advent of Shasta Genstrip at ISCR will probably reduce existing sales in its core diabetes supplies
by an estimated $3 million due to “cannibalization,” year-over-year. We will also opine that the $46 million
of Genstrip sales forecasted for 2011 is conservative: it could be as much as $56 million. Therefore, 2011
Sales are better seen as growing to a range of $65 million - $75 million in 2011.

http://www.instacare.net/documents/Walling_110124Guidance.pdf